AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21755811 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (dorzolamide 20 mg/ml + timolol 5 mg/ml eye drops)
Number of subjects: 38
Study 19851157 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity TENS (2 Hz, 250 mu) applied for 30 minutes
Number of subjects: 40
Study 19851157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity TENS (2 Hz, 250 mu) applied for 30 minutes
Number of subjects: 40
Study 19851157 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS applied for 30 minutes
Number of subjects: 40
Study 19851157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TENS applied)
Number of subjects: 40
Study 19851157 — intervention group
Group type: EXPERIMENTAL
Intervention: All TENS groups (high-intensity, low-intensity, placebo)
Number of subjects: 40
Study 16430342 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg BID
Number of subjects: 237
Study 16430342 — intervention group
Group type: COMPARATOR
Intervention: Routine care (gabapentin, amitriptyline, venlafaxine)
Number of subjects: 237
Study 16430342 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg BID and Routine care
Number of subjects: 237
Study 15291206 — intervention group
Group type: EXPERIMENTAL
Intervention: Right handers performing a constrained criterion movement with the right arm
Number of subjects: 30
Study 15291206 — intervention group
Group type: EXPERIMENTAL
Intervention: Left handers performing a constrained criterion movement with the left arm
Number of subjects: 30
Study 15291206 — intervention group
Group type: EXPERIMENTAL
Intervention: Right handers and left handers
Number of subjects: 30
Study 11406858 — intervention group
Group type: EXPERIMENTAL
Intervention: Procyanidin B-2 (1% tonic)
Number of subjects: 29
Study 8708952 — intervention group
Group type: EXPERIMENTAL
Intervention: bioresorbable membranes
Number of subjects: 36
Study 8708952 — intervention group
Group type: COMPARATOR
Intervention: non-resorbable (ePTFE) barrier membranes
Number of subjects: 36
Study 8708952 — intervention group
Group type: COMPARATOR
Intervention: access flap procedure (MWF)
Number of subjects: 36
Study 1907087 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 303
Study 1907087 — intervention group
Group type: COMPARATOR
Intervention: Intravenous thrombolytic therapy
Number of subjects: 303
Study 6311392 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with cyclophosphamide (1.5 g/m2 days 1‐3), 4‐dimethyl epipodophylloxtin (200 mg/m2 days 1‐3), vincristine (1.5 mg/m2 days 1 and 3), and Adriamycin (80 mg/m2 day 1)
Number of subjects: 14
Study 6311392 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy without Adriamycin
Number of subjects: 14
Study 6311392 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation (3000 rad) and 4 courses of usual doses of the same drugs
Number of subjects: 14
Study 30872550 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based video education + behaviour contract plus usual care
Number of subjects: 200
Study 30872550 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 200
Study 28498636 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bowel stimulation via the distal limb of the loop ileostomy using an 18Fr Foley catheter and infusing with 500 ml of normal saline mixed with 30 g of a thickening agent (Nestle© Thicken‐Up©), performed 10 times over 3 weeks before ileostomy closure.
Number of subjects: 0
Study 28498636 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group not explicitly defined in the abstract).
Number of subjects: 0
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutations detected by Sanger/qPCR
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutations detected by NGS
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobular histology, low tumor grade, and luminal A tumors
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: Luminal B tumors
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of PIK3CA mutations
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence and type of PIK3CA mutations
Number of subjects: 1008
Study 26452060 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mutation status and PTEN low protein expression
Number of subjects: 1008
Study 22951284 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance strength training
Number of subjects: 0
Study 22951284 — intervention group
Group type: COMPARATOR
Intervention: Lifting a light load under uncertainty
Number of subjects: 0
Study 21252171 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose (LD)/10 mg maintenance dose (MD)
Number of subjects: 35
Study 21252171 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/150 mg MD
Number of subjects: 35
Study 19339838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux 1.5 mg once daily
Number of subjects: 353
Study 17432637 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Taiyang (EX-HN 5)
Number of subjects: 300
Study 17432637 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of western medicine
Number of subjects: 300
Study 15851115 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical approach (group I)
Number of subjects: 32
Study 15851115 — intervention group
Group type: COMPARATOR
Intervention: Voltage-guided approach (group II)
Number of subjects: 32
Study 11558009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal Nerve Block (ICB) with Bupivacaine (BUP) 3 mg/kg 0.5 % with epinephrine 1 : 200 000
Number of subjects: 20
Study 11558009 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 1 mg/kg administered i.v.
Number of subjects: 20
Study 9626638 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH (400 IU/day subcutaneous human PTH (1-34)) + alendronate (10 mg/day)
Number of subjects: 10
Study 9626638 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (10 mg/day) alone
Number of subjects: 10
Study 7840332 — intervention group
Group type: EXPERIMENTAL
Intervention: Older men (aged 60-75 years)
Number of subjects: 2
Study 7840332 — intervention group
Group type: COMPARATOR
Intervention: Younger men (aged 20-30 years)
Number of subjects: 2
Study 2646848 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bupivacaine 0.5% 20 ml with adrenaline (5 micrograms/ml) administered through an indwelling intrapleural catheter at 4-hour intervals four times daily for 2 days.
Number of subjects: 0
Study 2646848 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular oxycodone on request (control group).
Number of subjects: 0
Study 1101615 — intervention group
Group type: EXPERIMENTAL
Intervention: etidocaine 1% with adrenaline 5 mug/ml
Number of subjects: 40
Study 1101615 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.5% with adrenaline 5 mug/ml
Number of subjects: 40
Study 31315649 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 28100527 — intervention group
Group type: EXPERIMENTAL
Intervention: THRIVE with jaw support and age-specific flow rates
Number of subjects: 48
Study 28100527 — intervention group
Group type: COMPARATOR
Intervention: Control with jaw support during apnoea
Number of subjects: 48
Study 26434745 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage surgical protocol (Group I)
Number of subjects: 16
Study 26434745 — intervention group
Group type: COMPARATOR
Intervention: Two-stage surgical protocol (Group II)
Number of subjects: 16
Study 23341738 — intervention group
Group type: EXPERIMENTAL
Intervention: multicomponent training
Number of subjects: 42
Study 23341738 — intervention group
Group type: EXPERIMENTAL
Intervention: progressive resistance training
Number of subjects: 42
Study 22180711 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG + Asc (low-volume plus ascorbic acid)
Number of subjects: 144
Study 22180711 — intervention group
Group type: COMPARATOR
Intervention: PEG + Sim (high-volume plus simethicone)
Number of subjects: 144
Study 19426557 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive website designed to empower claimants, consisting of five interactive modules and additional resources.
Number of subjects: 230
Study 19426557 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive website designed to empower claimants.
Number of subjects: 230
Study 19426557 — intervention group
Group type: COMPARATOR
Intervention: Control group directed to a website with commonly available information only.
Number of subjects: 230
Study 17019993 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffractive lens SA60D3
Number of subjects: 29
Study 17019993 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofocal lens MA60BM
Number of subjects: 29
Study 17019993 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (clear own lens)
Number of subjects: 29
Study 15333165 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (high-glucose drink)
Number of subjects: 10
Study 15333165 — intervention group
Group type: EXPERIMENTAL
Intervention: Fanta Orange (intermediate-GI drink)
Number of subjects: 10
Study 15333165 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple & Cherry Juice (low-GI drink)
Number of subjects: 10
Study 15333165 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10
Study 10773182 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant agents
Number of subjects: 0
Study 10773182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9483814 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical anaesthesia (2 x 10 ml 0.5% Bupivacain solution)
Number of subjects: 20
Study 9483814 — intervention group
Group type: COMPARATOR
Intervention: Only Pethidin intravenously and Butylscopolamine rectally
Number of subjects: 20
Study 8416441 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoladex (goserelin 3.6 mg) implant every 4 weeks plus estradiol valerate, 2 mg/day, with norethisterone 5 mg from days 22-28
Number of subjects: 60
Study 8416441 — intervention group
Group type: COMPARATOR
Intervention: Zoladex (goserelin 3.6 mg) implant every 4 weeks plus placebo ERT tablets daily
Number of subjects: 60
Study 8416441 — intervention group
Group type: COMPARATOR
Intervention: Placebo implant every 4 weeks plus placebo ERT tablets daily
Number of subjects: 60
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 10 mg ketanserin
Number of subjects: 10
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 10 mg ketanserin
Number of subjects: 10
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 20 mg ketanserin
Number of subjects: 10
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 40 mg ketanserin
Number of subjects: 10
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 60 mg ketanserin
Number of subjects: 10
Study 3792432 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin-ol (metabolite)
Number of subjects: 10
Study 30176891 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 102
Study 30176891 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 102
Study 27471203 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salbutamol
Number of subjects: 10
Study 27471203 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol
Number of subjects: 10
Study 25158551 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL at 80 shots per minute (group A)
Number of subjects: 247
Study 25158551 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL at 60 shots per minute (group B)
Number of subjects: 247
Study 25158551 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL at 45 shots per minute (group C)
Number of subjects: 247
Study 25158551 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL at 30 shots per minute (group D)
Number of subjects: 247
Study 22677347 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐assisted thoracoscopic surgery (VATS)
Number of subjects: 37
Study 22677347 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 37
Study 20018575 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 200mg
Number of subjects: 297
Study 20018575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 18782439 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 mg sCT with 50 ml of water
Number of subjects: 56
Study 18782439 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 mg sCT with 50 ml of water taken 30 and 60 minutes prior to meal time
Number of subjects: 56
Study 18782439 — intervention group
Group type: COMPARATOR
Intervention: nasal calcitonin
Number of subjects: 56
Study 15940460 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg erythromycin
Number of subjects: 35
Study 15940460 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg erythromycin
Number of subjects: 35
Study 15940460 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (0.9%)
Number of subjects: 35
Study 11819022 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 58
Study 11819022 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 58
Study 10071275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (90 mg, 2-hour intravenous infusion every 4 weeks for 24 cycles)
Number of subjects: 372
Study 10071275 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2-hour intravenous infusion every 4 weeks for 24 cycles)
Number of subjects: 372
Study 7564371 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD (once-daily controlled-delivery)
Number of subjects: 35
Study 7564371 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem SR (twice-daily sustained-release)
Number of subjects: 35
Study 2208927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioversol (Optiray Mallinckrodt Inc.)
Number of subjects: 80
Study 2208927 — intervention group
Group type: COMPARATOR
Intervention: Iohexol (Omnipaque, Nycomed [UK] Ltd)
Number of subjects: 80
Study 2208927 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Ioversol and Iohexol
Number of subjects: 80
Study 550366 — intervention group
Group type: EXPERIMENTAL
Intervention: Softened water
Number of subjects: 28
Study 550366 — intervention group
Group type: COMPARATOR
Intervention: De-ionized water
Number of subjects: 28
Study 31863149 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary program
Number of subjects: 152
Study 31863149 — intervention group
Group type: COMPARATOR
Intervention: No diet
Number of subjects: 152
Study 31008950 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 349
Study 31008950 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (SA)
Number of subjects: 349
Study 31008950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EA and SA
Number of subjects: 349
Study 28540844 — intervention group
Group type: EXPERIMENTAL
Intervention: Fp MDPI 200 μg
Number of subjects: 674
Study 28540844 — intervention group
Group type: EXPERIMENTAL
Intervention: FS MDPI 200/12.5 μg
Number of subjects: 674
Study 28540844 — intervention group
Group type: COMPARATOR
Intervention: Fp HFA 440 μg
Number of subjects: 674
Study 28540844 — intervention group
Group type: COMPARATOR
Intervention: FS DPI 500/50 μg
Number of subjects: 674
Study 28540844 — intervention group
Group type: COMPARATOR
Intervention: All Fp MDPI doses
Number of subjects: 674
Study 28540844 — intervention group
Group type: COMPARATOR
Intervention: All FS MDPI doses
Number of subjects: 674
Study 28540844 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 674
Study 25839338 — intervention group
Group type: EXPERIMENTAL
Intervention: Shakuyaku-Kanzo-to (7.5 g/d)
Number of subjects: 22
Study 25839338 — intervention group
Group type: COMPARATOR
Intervention: Biperiden (3 mg/d)
Number of subjects: 22
Study 24004620 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged use of aspirin before tooth extraction (observation group I)
Number of subjects: 300
Study 24004620 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged use of aspirin before tooth extraction (observation group II)
Number of subjects: 300
Study 24004620 — intervention group
Group type: COMPARATOR
Intervention: No aspirin before tooth extraction (control group I)
Number of subjects: 300
Study 24004620 — intervention group
Group type: COMPARATOR
Intervention: No aspirin before tooth extraction (control group II)
Number of subjects: 300
Study 21871072 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized small bites technique
Number of subjects: 576
Study 21871072 — intervention group
Group type: COMPARATOR
Intervention: Standardized large bites technique
Number of subjects: 576
Study 19796561 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored rehabilitation program including hand and face specific rehabilitation, global rehabilitation techniques (hydrokinesytherapy or land-based program), respiratory exercises, and hand lymphatic drainage when necessary.
Number of subjects: 20
Study 19796561 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored rehabilitation program (same as above)
Number of subjects: 20
Study 19796561 — intervention group
Group type: COMPARATOR
Intervention: Educational advice and medical information about SSc (observational group)
Number of subjects: 20
Study 18076441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal valsalva
Number of subjects: 26
Study 18076441 — intervention group
Group type: COMPARATOR
Intervention: Trumpet manoeuvre
Number of subjects: 26
Study 15347767 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented infant formula (FIF)
Number of subjects: 30
Study 15347767 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (placebo)
Number of subjects: 30
Study 12577329 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi Zengmian Powder (HQZMP)
Number of subjects: 37
Study 12577329 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-HQZMP treated)
Number of subjects: 37
Study 9875910 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH (continuous venovenous hemofiltration)
Number of subjects: 13
Study 9875910 — intervention group
Group type: COMPARATOR
Intervention: CVVHD (continuous venovenous hemodialysis)
Number of subjects: 13
Study 9875910 — intervention group
Group type: COMPARATOR
Intervention: CVVHD
Number of subjects: 13
Study 9875910 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH
Number of subjects: 13
Study 9875910 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH and CVVHD
Number of subjects: 13
Study 7986770 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 25
Study 7986770 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine
Number of subjects: 25
Study 7986770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2915556 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh whole blood
Number of subjects: 24
Study 2915556 — intervention group
Group type: COMPARATOR
Intervention: Platelet concentrates (8 units)
Number of subjects: 24
Study 2915556 — intervention group
Group type: COMPARATOR
Intervention: Platelet concentrates (10 units)
Number of subjects: 24
Study 5082545 — intervention group
Group type: EXPERIMENTAL
Intervention: Metolazone (doses ranging from 20-150 mg)
Number of subjects: 14
Study 29098425 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA-enriched breakfast
Number of subjects: 18
Study 29098425 — intervention group
Group type: COMPARATOR
Intervention: unSFA and fiber-enriched breakfast
Number of subjects: 18
Study 29098425 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA-enriched meal test
Number of subjects: 18
Study 29098425 — intervention group
Group type: COMPARATOR
Intervention: unSFA meal
Number of subjects: 18
Study 27757552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 906
Study 26334629 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person motivational interviewing (MI) plus usual care (UC)
Number of subjects: 159
Study 26334629 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based motivational interviewing (web-MI) plus usual care (UC)
Number of subjects: 159
Study 26334629 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) only
Number of subjects: 159
Study 23469947 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Zn, vitamin B12, and a-tocopherol
Number of subjects: 285
Study 23469947 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma g-tocopherol
Number of subjects: 285
Study 21510895 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg in divided b.i.d. dose)
Number of subjects: 157
Study 21510895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 21510895 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 157
Study 18339033 — intervention group
Group type: EXPERIMENTAL
Intervention: ELISA (Hitazyme Chlamydophila pneumoniae)
Number of subjects: 100
Study 18339033 — intervention group
Group type: COMPARATOR
Intervention: MIF test or immunoblot
Number of subjects: 100
Study 15798460 — intervention group
Group type: EXPERIMENTAL
Intervention: Beger procedure
Number of subjects: 74
Study 15798460 — intervention group
Group type: EXPERIMENTAL
Intervention: Frey procedure
Number of subjects: 74
Study 12640250 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 20
Study 10378563 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifier (Fisher & Paykel; Auckland, New Zealand)
Number of subjects: 45
Study 10378563 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygrobac‐Dar (Mallinckrodt, Mirandola, Italy)
Number of subjects: 45
Study 10378563 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual evaluation of condensation in the flex‐tube
Number of subjects: 45
Study 8635258 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 4444
Study 8635258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4444
Study 1506150 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10 mmol/kg gadoteridol
Number of subjects: 411